Axis Securities is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 665 in its research report dated July 25 2023.

Buy Aarti Drugs; target of Rs 844: Anand Rathi

Anand Rathi is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 844 in its research report dated July 28, 2021.

Buy Aarti Drugs; target of Rs 848: Anand Rathi

Anand Rathi is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 848 in its research report dated January 27, 2021.

Buy Aarti Drugs; target of Rs 813: Anand Rathi

Anand Rathi is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 813 in its research report dated October 28, 2020.

Buy Aarti Drugs; target of Rs 2090: Anand Rathi

Anand Rathi is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 2090 in its research report dated July 28, 2020.

Buy Aarti Drugs; target of Rs 1028: Anand Rathi

Anand Rathi is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 1028 in its research report dated May 19, 2020.

Buy Aarti Drugs; target of Rs 745: Anand Rathi

Anand Rathi is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 745 in its research report dated November 21, 2018.

Buy Aarti Drugs; target of Rs 910: Centrum

Centrum is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 910 in its research report dated October 04, 2018.

Buy Aarti Drugs; target of Rs 960: Centrum

Centrum is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 960 in its research report dated May 17, 2018.

Buy Aarti Drugs; target of Rs 940: Centrum Research

Centrum Research is bullish on Aarti Drugs has recommended buy rating on the stock with a target price of Rs 940 in its research report dated January 15, 2018.

Buy Aarti Drugs; target of Rs 705: Motilal Oswal

Motilal Oswal is bullish on Suprajit Eng has recommended buy rating on the stock with a target price of Rs 705 in its research report dated Februrary 10, 2016.

Buy Aarti Drugs; target of Rs 790: Firstcall

Brokerage house Firstcall Research is bullish on Aarti Drugs and has recommended buy rating on the stock with a target price of Rs 790 in its research report dated August 3, 2015.

Buy Aarti Drugs; target of Rs 240: Firstcall Research

Brokerage house Firstcall Research is bullish on Aarti Drugs and has recommended buy rating on the stock with a target price of Rs 240 in its January 06, 2014 research report.

Buy Aarti Drugs; target Rs 260: Sunidhi Securities

Sunidhi Securities is bullish on Aarti Drugs (ADL) and has recommended buy rating on the stock with a price target of Rs 260 in its June 26, 2013 research report.

Buy Aarti Drugs; target of Rs 210: Sunidhi Securities

Sunidhi Securities is bullish on Aarti Drugs and has recommended buy rating on the stock with a target of Rs 210 in its April 09, 2013 research report.

Buy Aarti Drugs; target of Rs 175: Firstcall Research

Firstcall Research is bullish on Aarti Drugs and has recommended buy rating on the stock with a target of Rs 175 in its April 4, 2013 research report.